ArticleCancer management and research2022

Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy.

Chengliang Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.